UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   May 18, 2011

Health Net, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 1-12718 95-4288333
_____________________
(State or other jurisdiction
_____________
(Commission
______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
21650 Oxnard Street, Woodland Hills, California   91367
_________________________________
(Address of principal executive offices)
  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   (818) 676-6000

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.07. Submission of Matters to a Vote of Security Holders

(a) Health Net, Inc. (the “Company”) held its Annual Meeting of Stockholders in Woodland Hills, California on May 18, 2011 (the “Annual Meeting”).

(b) At the Annual Meeting, the stockholders (1) elected all of the Company’s nominees for director, (2) ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered accounting firm for 2011, (3) approved, on an advisory basis, the compensation of the Company’s named executive officers, (4) approved, on an advisory basis, one year as the frequency with which future advisory votes will be held to approve the compensation of the Company’s named executive officers and (5) approved an amendment and restatement of the Company’s certificate of incorporation to eliminate its supermajority voting requirements, with the voting results set forth below.

Proposal 1: To elect the following nine directors to serve for a term of one year or until the 2012 Annual Meeting of Stockholders.

                                     
Name
       For   Against   Abstain   Broker Non-Votes
 
                                   
Mary Anne Citrino
         76,676,423       4,197,636       26,149       3,517,393  
Theodore F. Craver, Jr.
         77,303,381       3,561,419       35,408       3,517,393  
Vicki B. Escarra
         78,755,266       2,122,651       22,291       3,517,393  
Gale S. Fitzgerald
         79,410,157       1,459,750       30,301       3,517,393  
Patrick Foley
         78,115,156       2,752,754       32,298       3,517,393  
Jay M. Gellert
         79,207,340       1,671,727       21,141       3,517,393  
Roger F. Greaves
         79,134,261       1,738,439       27,508       3,517,393  
Bruce G. Willison
         71,887,860       8,973,911       38,437       3,517,393  
Frederick C. Yeager
         79,440,712       1,433,092       26,404       3,517,393  

Proposal 2: Ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for 2011.

                                     
For
       Against        Abstain        Broker Non-Votes
 
                                   
83,460,799
        931,013           25,789           0  

Proposal 3: Approval, on an advisory basis, of the compensation of the Company’s named executive officers, as described in the Compensation Discussion and Analysis section and the related tabular and narrative disclosure set forth in the Company’s proxy statement for the Annual Meeting.

                                     
For
       Against        Abstain        Broker Non-Votes
 
                                   
68,013,700
        12,831,014           55,494           3,517,393  

Proposal 4: Approval, on an advisory basis, of the frequency with which future advisory votes will be held to approve the compensation of the Company’s named executive officers.

                                                 
1 Year
       2 Years        3 Years        Abstain        Broker Non-Votes
 
                                               
71,110,598
        197,888           9,522,482           69,240           3,517,393  

Proposal 5: Proposal to amend and restate the Company’s certificate of incorporation to eliminate its supermajority voting requirements.

                                     
For
       Against        Abstain        Broker Non-Votes
 
                                   
83,576,319
        799,320           41,962           0  

(c) Not applicable.

(d) On May 18, 2011, following the Annual Meeting and after considering the results of the vote on the frequency with which future advisory votes on the compensation of the Company’s named executive officers will be held (the “Frequency Vote”), the Company’s Board of Directors determined to hold future advisory votes on the compensation of our named executive officers on an annual basis until the next Frequency Vote.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Health Net, Inc.
          
May 19, 2011   By:   /s/ Angelee F. Bouchard
       
        Name: Angelee F. Bouchard
        Title: Senior Vice President, General Counsel and Secretary